To the Editor We read with interest the article by Muramatsu et al. about a 24-year-old female with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) due to the mtDNA variant m.3243A>G, who developed stroke-like lesions (SLLs) in the cerebellum, which spontaneously disappeared at 6 months after onset (1). We have the following comments and concerns.
by Muramatsu, one would expect not only nausea, but also vertigo, nystagmus, dysarthria, and ataxia. Did the patient present with any other typical manifestations of a cerebellar lesion?
Since mtDNA variants are inherited via a maternal trait in 75% of the cases (4), we should be informed about the family history, particularly if the mother was genotypically or phenotypically affected.
Since SLLs are frequently treated with NO-precursors, antiepileptic drugs, steroids, or antioxidants (CoQ, edaravone, idebenone) (5), we should know if the described patient received any treatment for the SLL, for how long, and at what dosages.
Overall, this interesting article could be more meaningful, if more basic information concerning the individual and family history, multisystem involvement, and treatment had been provided. There is also a need to discuss in more detail the cause and pathophysiology of the described cerebellar lesions.
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